* Targeted Genetics Corp., of Seattle, received patent No. 5,470,726,covering a retrovirus packaging cell line, called PG13, which is usedto produce retroviral vectors for gene transfer. The patent is co-owned by the Fred Hutchinson Cancer Research Center, in Seattle.
* VivoRx Inc., of Santa Monica, Calif., received a patent coveringcomposition and method for encapsulating biologically activematerials, such as cells, in natural and synthetic polymers.
* Xoma Corp., of Berkeley, Calif., received two patents related tomanufacturing capability and basic research for itsbactericidal/permeability-increasing protein (BPI). Patent No.5,488,034 covers pharmaceutical forms of BPI for storage andshipping and patent No. 5,489,676, covers polypeptides that mayboost BPI's ability to kill gram-negative bacteria.
(c) 1997 American Health Consultants. All rights reserved.